Electromed, Inc. (NYSE:ELMD) Shares Acquired by Pekin Hardy Strauss Inc.

Pekin Hardy Strauss Inc. boosted its holdings in shares of Electromed, Inc. (NYSE:ELMD) by 9.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 38,185 shares of the company’s stock after purchasing an additional 3,435 shares during the period. Pekin Hardy Strauss Inc. owned approximately 0.45% of Electromed worth $820,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Morgan Dempsey Capital Management LLC acquired a new stake in Electromed during the second quarter valued at approximately $108,000. Marshall Wace LLP purchased a new stake in shares of Electromed in the 2nd quarter valued at approximately $256,000. Navellier & Associates Inc. acquired a new position in Electromed in the 3rd quarter valued at approximately $368,000. Gabelli Funds LLC increased its stake in Electromed by 76.1% in the 1st quarter. Gabelli Funds LLC now owns 35,867 shares of the company’s stock valued at $579,000 after buying an additional 15,500 shares during the period. Finally, Hunter Associates Investment Management LLC increased its stake in shares of Electromed by 12.3% during the 3rd quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,250 shares during the last quarter. 40.82% of the stock is owned by institutional investors and hedge funds.

Electromed Stock Up 6.1 %

Shares of ELMD opened at $29.79 on Monday. The company’s fifty day moving average is $23.23 and its 200-day moving average is $18.20. The firm has a market cap of $252.02 million, a price-to-earnings ratio of 41.38 and a beta of 0.27. Electromed, Inc. has a 12 month low of $9.81 and a 12 month high of $30.00.

Electromed (NYSE:ELMD) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13. The business had revenue of $14.67 million during the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.